A Clinical Study to Evaluate the Steady State Pharmacokinetics of Baraclude in Participants With Hepatitis B Virus Infection
Phase of Trial: Phase I
Latest Information Update: 13 Mar 2018
Price : $35 *
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 08 Mar 2018 Status changed from recruiting to completed.
- 09 Oct 2017 Planned End Date changed from 29 Sep 2017 to 29 Dec 2017.
- 09 Oct 2017 Planned primary completion date changed from 29 Sep 2017 to 29 Dec 2017.